Finasteride and Proviron Interaction

Avoid
Researched 95% confidence

Finasteride and Proviron have a potentially harmful interaction with 95% confidence. Finasteride blocks the conversion of testosterone to DHT via 5-alpha reductase inhibition. Proviron is a DHT derivative whose effects depend on direct androgenic receptor activation as a DHT analogue. While finasteride does not directly deactivate Proviron, the combination is pharmacologically contradictory — one compound is a DHT agonist and the other suppresses DHT production. Concurrent use undermines the rationale for using either compound and may produce unpredictable androgenic signaling. These compounds primarily affect different organ systems.

Compound Profiles

Finasteride

5-Alpha Reductase Inhibitor | DHT Blocker for Hair Loss & BPH

Finasteride competitively and selectively inhibits the Type II isoform of the enzyme 5-alpha reductase, which is predominantly found in hair follicles, the prostate, and the liver. This enzyme converts testosterone into dihydrotestosterone (DHT).

Half-life: 6-8 hours (DHT suppression persists ~24 hours) Typical dose: 1mg/day (hair loss) or 5mg/day (BPH) hair loss
5 alpha reductase estrogenichepatotoxicteratogenic
View full profile

Proviron

DHT Derivative | Mood, Libido & Muscle Hardening

Proviron exerts its effects primarily through direct binding to the androgen receptor (AR) as a potent DHT analogue. However, its most therapeutically relevant mechanism is its exceptionally high binding affinity for sex hormone-binding globulin (SHBG).

Half-life: ~12 hours Typical dose: 25-75 mg/day anabolic, sexual health
androgen receptoraromataseepo receptorshbg androgenicaromatase inhibitorcarcinogenic riskhepatotoxic
View full profile

Combined Organ Load

Gonads
moderate
Liver
moderate
Heart
low
Skin
low

Shared Safety Flags

2x 2 hepatotoxic compounds (Finasteride, Proviron). Liver damage risk significantly increased. Include liver support (TUDCA/NAC) and monitor ALT/AST.
2x 2 compounds share the teratogenic safety flag (Finasteride, Proviron). Monitor accordingly.

Frequently Asked Questions

Can I take Finasteride with Proviron?

Combining Finasteride with Proviron is not recommended. Finasteride blocks the conversion of testosterone to DHT via 5-alpha reductase inhibition. Proviron is a DHT derivative whose effects depend on direct androgenic receptor activation as a DHT analogue. While finasteride does not directly deactivate Proviron, the combination is pharmacologically contradictory — one compound is a DHT agonist and the other suppresses DHT production. Concurrent use undermines the rationale for using either compound and may produce unpredictable androgenic signaling.

Is Finasteride and Proviron safe together?

This combination carries significant risk. Finasteride blocks the conversion of testosterone to DHT via 5-alpha reductase inhibition. Proviron is a DHT derivative whose effects depend on direct androgenic receptor activation as a DHT analogue. While finasteride does not directly deactivate Proviron, the combination is pharmacologically contradictory — one compound is a DHT agonist and the other suppresses DHT production. Concurrent use undermines the rationale for using either compound and may produce unpredictable androgenic signaling. Consult a healthcare professional before combining.

What are the interactions between Finasteride and Proviron?

Finasteride blocks the conversion of testosterone to DHT via 5-alpha reductase inhibition. Proviron is a DHT derivative whose effects depend on direct androgenic receptor activation as a DHT analogue. While finasteride does not directly deactivate Proviron, the combination is pharmacologically contradictory — one compound is a DHT agonist and the other suppresses DHT production. Concurrent use undermines the rationale for using either compound and may produce unpredictable androgenic signaling. This assessment has 95% confidence and is based on documented research data.

How should I time Finasteride and Proviron?

Finasteride has a half-life of 6-8 hours (DHT suppression persists ~24 hours) and Proviron has a half-life of ~12 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: Finasteride vs Proviron

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.